Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Camson Biotechnologies is an Indian agricultural biotechnology company that pioneered the use of secondary metabolites for crop protection and nutrition. The company developed a range of zero-residue products, including bio-pesticides, bio-fertilizers, and hybrid seeds, aimed at sustainable farming. Headquartered in Bangalore, it focused on replacing synthetic chemicals with microbial-based solutions. However, the company entered insolvency proceedings and has faced delisting from the Bombay Stock Exchange due to financial distress. Despite these challenges, its research into microbial fermentation and metabolite extraction remains a notable contribution to the Indian agri-biotech sector. The company's product portfolio was designed to improve soil health and crop yields while ensuring environmental safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Camson Biotechnologies.